文献速递慢阻肺

慢性阻塞性肺疾病患者结局价值评估的系统综述

A systematic review of how patients value COPD outcomes.
PubMed 文献 · Eur Respir J · 2018-07-19

该研究系统检索并汇总了评估慢阻肺患者结局相对重要性的研究,纳入217项定量研究。多数研究采用效用测量、离散选择实验等技术。患者认为不良事件重要但平均低于症状缓解,急性加重及因急性加重住院是患者最重视的结局。

要点

  • 慢阻肺患者最重视的结局是急性加重和因急性加重住院。
  • 患者认为不良事件重要,但平均而言重要性低于症状缓解。
  • 该综述提供了慢阻肺患者结局价值评估研究的全面注册信息。

核心结论

  • 慢阻肺患者将急性加重和因急性加重住院评为最重要的结局。
  • 患者认为不良事件重要,但平均而言重要性低于症状缓解。

研究设计与样本

  • 系统综述,注册号CRD42015015206,检索PubMed、Embase、PsycInfo和CINAHL。
  • 纳入从慢阻肺患者视角评估结局相对重要性的报告,两位作者独立判断纳入资格、提取数据并评估偏倚风险。
  • 共纳入217项定量研究。

主要发现

  • 研究最常使用结局效用测量(n=136),其次为强制选择技术(n=46)、离散选择实验(n=13)和概率权衡(n=4)。
  • 患者认为不良事件重要,但平均而言重要性低于症状缓解。
  • 急性加重和因急性加重住院是患者最重视的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our objective was to summarise systematically all research evidence related to how patients value outcomes in chronic obstructive pulmonary disease (COPD).We conducted a systematic review (systematic review registration number CRD42015015206) by searching PubMed, Embase, PsycInfo and CINAHL, and included reports that assessed the relative importance of outcomes from COPD patients' perspective. Two authors independently determined the eligibility of studies, abstracted the eligible studies and assessed risk of bias. We narratively summarised eligible studies, meta-analysed utilities for individual outcomes and assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluations approach.We included 217 quantitative studies. Investigators most commonly used utility measurements of outcomes (n=136), discrete choice exercises (n=13), probability trade-off (n=4) and forced choice techniques (n=46). Patients rated adverse events as important but on average, less so than symptom relief. Exacerbation and hospitalisation due to exacerbation are the outcomes that COPD patients rate as most important. This systematic review provides a comprehensive registry of related studies.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Morgan RL, Alonso-Coello P, et al. A systematic review of how patients value COPD outcomes. Eur Respir J. 2018. PMID: 30002103. doi:10.1183/13993003.00222-2018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。